Todd Young
Director of Finance/CFO bei ELANCO ANIMAL HEALTH INCORPORATED
Vermögen: 4 Mio $ am 31.03.2024
Aktive Positionen von Todd Young
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELANCO ANIMAL HEALTH INCORPORATED | Director of Finance/CFO | 14.12.2018 | - |
Karriereverlauf von Todd Young
Ehemalige bekannte Positionen von Todd Young
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 22.08.2016 | 31.10.2018 |
| Director of Finance/CFO | 22.08.2016 | 31.10.2018 | |
| Sidley & Austin | Corporate Officer/Principal | - | - |
| BAXALTA INC | Corporate Officer/Principal | - | - |
| Treasurer | - | - | |
| BAXTER INTERNATIONAL INC. | Treasurer | 01.01.2001 | - |
Ausbildung von Todd Young
| Grinnell College | Undergraduate Degree |
| The University of Michigan Law School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Treasurer | 2 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
| Sidley & Austin | Commercial Services |
- Börse
- Insiders
- Todd Young
- Erfahrung
